Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes

被引:125
作者
Gerber, Y
Tanne, D
Medalie, JH
Goldbourt, U
机构
[1] Tel Aviv Univ, Sackler Fac Med, Div Epidemiol & Prevent Med, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Dept Neurol, Stroke Ctr, IL-52621 Tel Hashomer, Israel
[3] Case Western Reserve Univ, Dept Family Med, Cleveland, OH 44106 USA
[4] Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2006年 / 13卷 / 02期
关键词
coronary heart disease; epidemiology; longitudinal studies; mortality; stroke; uric acid;
D O I
10.1097/01.hjr.0000192745.26973.00
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background Increased serum uric acid (SUA) levels are linked to obesity, dyslipidemia, diabetes and hypertension. Whether SUA carries a risk for coronary heart disease (CHD) and stroke remains uncertain. Design A prospective cohort study. Methods Of an original cohort of middle-aged workers who were examined in 1963 and followed-up for 23 years, 9125 men, free of CHD at entry, are included in this study. Subjects were divided into quintiles according to baseline SUA levels. Hazard ratios (HR) for all-cause, CHD, and stroke mortality were estimated in SUA quintiles, with the third serving as a referent Results During follow-up, 2893 deaths were recorded, including 830 ascribed to CHD and 292 to stroke. The HR for all death [1.22, 95% confidence interval (CI) 1.09-1.37] and CHD (1.29, 95% Cl 1.05-1.58) were increased in the upper SUA quintile. Fatal stroke showed a U-shaped relationship as both the upper (HR 1.48, 95% Cl 1.02-2.17) and bottom (HR 1.43, 95% CI 0.99-2.08) quintiles were associated with a higher risk. Adjustment for confounders reduced the HR of the upper quintile for all outcomes, but did not attenuate the association of the bottom quintile with stroke (HR 1.52, 95% CI 1.04-2.23). When analysed separately by stroke type, the latter association seemed to be stronger for hemorrhagic (HR 3.27, 95% C1 1.14-9.33) than for ischemic stroke (HR 1.34, 95% Cl 0.87-2.05). Conclusion In addition to findings supporting increased mortality among hyperuricemic subjects, we identified an association between low SUA levels and fatal stroke, which deserves further investigation.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 37 条
[1]
Uric acid: role in cardiovascular disease and effects of losartan [J].
Alderman, M ;
Aiyer, KJV .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) :369-379
[2]
Uric acid and cardiovascular risk [J].
Alderman, MH .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (02) :126-130
[3]
ANDERSON JT, 1956, CLIN CHEM, V2, P145
[4]
HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[5]
Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke [J].
Chamorro, A ;
Obach, V ;
Cervera, A ;
Revilla, M ;
Deulofeu, R ;
Aponte, JH .
STROKE, 2002, 33 (04) :1048-1052
[6]
Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[7]
Is raised serum uric acid a cause of cardiovascular disease or death? [J].
Dobson, A .
LANCET, 1999, 354 (9190) :1578-1578
[8]
RELATIONSHIP BETWEEN RESISTANCE TO INSULIN-MEDIATED GLUCOSE-UPTAKE, URINARY URIC-ACID CLEARANCE, AND PLASMA URIC-ACID CONCENTRATION [J].
FACCHINI, F ;
CHEN, YDI ;
HOLLENBECK, CB ;
REAVEN, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (21) :3008-3011
[9]
Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410
[10]
EFFECT OF INSULIN ON URIC-ACID EXCRETION IN HUMANS [J].
GALVAN, AQ ;
NATALI, A ;
BALDI, S ;
FRASCERRA, S ;
SANNA, G ;
CIOCIARO, D ;
FERRANNINI, E .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (01) :E1-E5